Skip to main content

Table 4 Distribution of antibiotics prescribed based on indications

From: Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey

AntibioticCIHISP3MPUI
Ciprofloxacin29 (16.7)8 (11.0)7 (6.9)4 (6.0)7 (20.6)
Levofloxacin4 (2.3)0 (0.0)1 (1.0)1 (1.5)0 (0.0)
Ceftriaxone21 (12.1)6 (8.2)8 (7.9)13 (19.4)6 (17.6)
Cefuroxime6 (3.4)2 (2.7)9 (8.9)0 (0.0)0 (0.0)
Cefixime4 (2.3)4 (5.5)13 (12.9)0 (0.0)1 (2.9)
Ceftazidime1 (0.6)5 (6.8)0 (0.0)3 (4.5)0 (0.0)
Metronidazole41 (23.6)15 (20.5)21 (20.8)11 (16.4)11 (32.4)
Tinidazole5 (2.9)7 (9.6)13 (12.9)2 (3.0)1 (2.9)
Secnidazole0 (0.0)1 (1.4)0 (0.0)0 (0.0)0 (0.0)
Ampicillin-sulbactam2 (1.1)3 (4.1)0 (0.0)1 (1.5)1 (2.9)
Amoxicillin-clavulanate16 (9.2)5 (6.8)11 (10.9)6 (9.0)2 (5.9)
Amoxicillin6 (3.4)2 (2.7)8 (7.9)1 (1.5)1 (2.9)
Ampicillin-cloxacillin1 (0.6)1 (1.4)0 (0.0)8 (11.9)1 (2.9)
Ampicillin-floxacillin0 (0.0)0 (0.0)0 (0.0)0 (0.0)1 (2.9)
Crystalline penicillin4 (2.3)1 (1.4)0 (0.0)3 (4.5)0 (0.0)
Erythromycin1 (0.6)0 (0.0)1 (1.0)0 (0.0)0 (0.0)
Azithromycin5 (2.9)0 (0.0)0 (0.0)1 (1.5)0 (0.0)
Cotrimoxazole2 (1.1)1 (1.4)0 (0.0)1 (1.5)0 (0.0)
Doxycycline1 (0.6)0 (0.0)2 (2.0)0 (0.0)1 (2.9)
Chloramphenicol3 (1.7)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
Gentamicin13 (7.5)10 (13.7)4 (4.0)10 (14.9)1 (2.9)
Clindamycin9 (5.2)1 (1.4)3 (3.0)1 (1.5)0 (0.0)
Meropenem0 (0.0)1 (1.4)0 (0.0)0 (0.0)0 (0.0)
Nitrofurantoin0 (0.0)0 (0.0)0 (0.0)1 (1.5)0 (0.0)
  1. CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication